Sanofi
SAN
Real-time Euronext Paris - 04/25 05:35:22 pm
65.87EUR
+0.69%
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Sales35 05535 088
EBITDA-11 085
Operating profit (EBIT)8 3998 621
Pre-Tax Profit (EBT)5 5306 979
Net income8 4344 901
EPS ( € )6,714,04
Dividend per Share ( € )3,033,08
Yield4,22%4,70%
Announcement Date02/07/2018
06:36am
-
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Debt5 28614 450
Finance--
Operating income (EBITDA)-11 085
Leverage
(Debt/EBITDA)
-1,30x
Capital Expenditure-2 095
Book Value Per Share (BVPS)46,5 €47,5 €
Cash Flow per Share-6,43 €
Announcement Date02/07/2018
06:36am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 82 538 M€ -
Entreprise Value (EV) 96 988 M€ 95 011 M€
Valuation 2018e 2019e
P/E ratio (Price / EPS) 16,2x 14,3x
Capitalization / Revenue 2,35x 2,25x
EV / Revenue 2,76x 2,59x
EV / EBITDA 8,75x 8,18x
Yield (DPS / Price) 4,70% 4,87%
Price to book (Price / BVPS) 1,38x 1,35x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 24,6% 25,0%
operating Leverage (Delta EBIT / Delta Sales) 27,8x 1,37x
Net Margin (Net Profit / Revenue) 14,0% 15,6%
ROA (Net Profit / Asset) 6,18% 6,54%
ROE (Net Profit / Equities) 11,1% 12,2%
Rate of Dividend 76,1% 69,7%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   5,97% 4,80%
Cash Flow / Sales 23,0% 23,6%
Capital Intensity (Assets / Sales) 2,26x 2,39x
Financial Leverage (Net Debt / EBITDA) 1,30x 1,07x
Price Earning Ratio
BNA & Dividende